| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/1997 | WO1997001562A1 Nitroimidazole antibacterial compounds and methods of use thereof |
| 01/16/1997 | WO1997001559A1 Zinc(ii) complexes and methods related thereto |
| 01/16/1997 | WO1997001558A1 Novel substituted azabicyclic compounds |
| 01/16/1997 | WO1997001556A1 Novel substituted azacyclic or azabicyclic compounds |
| 01/16/1997 | WO1997001555A1 Novel substituted azacyclic compounds |
| 01/16/1997 | WO1997001554A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001552A1 Triazole antifungal agents |
| 01/16/1997 | WO1997001551A1 Pyrazole compounds and pharmaceutical compositions |
| 01/16/1997 | WO1997001549A1 Benzothiophene compounds |
| 01/16/1997 | WO1997001540A1 Integrin receptor antagonists |
| 01/16/1997 | WO1997001536A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001352A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | WO1997001349A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 01/16/1997 | WO1997001348A1 Pharmaceutical compositions containing herbal-based active ingredients; method for preparing same and uses of same for medical and veterinary purposes |
| 01/16/1997 | WO1997001347A1 Pharmaceutical composition for wound healing |
| 01/16/1997 | WO1997001344A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | WO1997001343A2 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin |
| 01/16/1997 | WO1997001342A1 Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 01/16/1997 | WO1997001341A1 The combination of topical nasal mast cell stabilizers and topical nasal steroids |
| 01/16/1997 | WO1997001340A1 The combination of topical nasal antihistamines and topical nasal mast cell stabilizers |
| 01/16/1997 | WO1997001339A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 01/16/1997 | WO1997001338A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | WO1997001337A1 The combination of topical nasal antihistamines and topical nasal steroids |
| 01/16/1997 | WO1997001336A1 Use of lamellarin-class alkaloids in methods of treatment |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | WO1997001334A1 Cytotoxic triterpenes from a marine sponge |
| 01/16/1997 | WO1997001333A1 Synergistic medicinal anti-cancer composition having several para-substituted phenols |
| 01/16/1997 | WO1997001332A1 Metabotropic glutamate receptor agonists for the treatment of traumatic cns-tissue |
| 01/16/1997 | WO1997001329A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 01/16/1997 | WO1997001325A1 Stable n-acetylcysteine compositions |
| 01/16/1997 | WO1997001275A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | WO1996036318A3 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525598A1 Schlafmittel Sleeping pills |
| 01/16/1997 | DE19519056A1 Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation Use of antidepressants for the treatment of asthma and / or respiratory diseases using inhalational application |
| 01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | CA2225691A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
| 01/16/1997 | CA2225682A1 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | CA2225255A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2224474A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2224437A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | CA2222273A1 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220991A1 Benzothiophene compounds |
| 01/15/1997 | EP0753582A1 Immunopotentiator and method of manufacturing the same |
| 01/15/1997 | EP0753523A1 Amino-substituted bisphosphonic acids |
| 01/15/1997 | EP0753518A1 A specific crystalline form of zilpaterol hydrochloride, process for its preparation and intermediates used |
| 01/15/1997 | EP0753517A2 Amides and sulfonamides of benzylamines with heterocyclic substituents |
| 01/15/1997 | EP0753512A1 N,N,-diethyl-8,8dipropyl-2-azaspiro(4,5)decane-2-propanamine dimaleate salt |
| 01/15/1997 | EP0753506A1 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents |
| 01/15/1997 | EP0753312A1 Arteriosclerosis remedy |
| 01/15/1997 | EP0753302A1 Osteoporosis preventing or treating agent |
| 01/15/1997 | EP0753301A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics |
| 01/15/1997 | EP0753300A1 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man |
| 01/15/1997 | EP0753299A1 A formulation for iron chelation and a process for preparing same |
| 01/15/1997 | EP0753298A1 Synergistic combination comprising an insulin sensitizer and a HMG-CoA reductase inhibitor for treating arteriosclerosis |
| 01/15/1997 | EP0753297A1 Lotion |
| 01/15/1997 | EP0753296A2 Oral formulations of S(+)-ibuprofen |
| 01/15/1997 | EP0753063A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0753002A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| 01/15/1997 | EP0753000A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 01/15/1997 | EP0752999A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them |
| 01/15/1997 | EP0752994A1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING THEM |
| 01/15/1997 | EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752992A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752989A1 Thiazolylpyrazolinones and their use for protecting technical materials |
| 01/15/1997 | EP0752988A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 01/15/1997 | EP0752982A1 Biphenyl derivatives as 5ht1d antagonists |
| 01/15/1997 | EP0752981A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists |
| 01/15/1997 | EP0752903A1 Solvent extraction process |
| 01/15/1997 | EP0752885A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
| 01/15/1997 | EP0752873A1 Labelled peptide compounds |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752871A1 Adhesion inhibiting composition |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0752866A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 01/15/1997 | EP0752865A1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions |
| 01/15/1997 | EP0752864A1 Use of growth factor protecting polymers for treating inflammation |
| 01/15/1997 | EP0752863A1 Use of biopolymers for digestive tract injuries treatment |
| 01/15/1997 | EP0752862A1 Use of biopolymers for the muscle treatment |
| 01/15/1997 | EP0752861A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 01/15/1997 | EP0752860A1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 01/15/1997 | EP0752859A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent |
| 01/15/1997 | EP0752858A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
| 01/15/1997 | EP0752857A1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT |